AS, R., JB, P., A, S., AE, P., DM, L., YC, L., . . . LC, P. (2024). Designing target trials using electronic health records: A case study of second-line disease-modifying anti-rheumatic drugs and cardiovascular disease outcomes in patients with rheumatoid arthritis. PloS one, 19(6), e0305467. https://doi.org/10.1371/journal.pone.0305467
Chicago Style (17th ed.) CitationAS, Rivera, Pierce JB, Sinha A, Pawlowski AE, Lloyd-Jones DM, Lee YC, Feinstein MJ, and Petito LC. "Designing Target Trials Using Electronic Health Records: A Case Study of Second-line Disease-modifying Anti-rheumatic Drugs and Cardiovascular Disease Outcomes in Patients with Rheumatoid Arthritis." PloS One 19, no. 6 (2024): e0305467. https://doi.org/10.1371/journal.pone.0305467.
MLA (9th ed.) CitationAS, Rivera, et al. "Designing Target Trials Using Electronic Health Records: A Case Study of Second-line Disease-modifying Anti-rheumatic Drugs and Cardiovascular Disease Outcomes in Patients with Rheumatoid Arthritis." PloS One, vol. 19, no. 6, 2024, p. e0305467, https://doi.org/10.1371/journal.pone.0305467.